Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/6923772e-905c-8010-9104-b8d007833c93
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== ## === Kenyan athlete Jackline Wambui tested positive on 21 September 2021 for metabolites of nandrolone (19-norandrosterone and 19-noretiocholanolone), a non-specified anabolic steroid prohibited at all times. The Kenyan Sports Disputes Tribunal (first instance, 29 September 2022; appeal instance, 25 January 2024) found: * ADRV for Articles 2.1 and 2.2 ADAK ADR * Two-year ban (crediting provisional suspension since 20 December 2021) * Acceptance of the Athlete’s explanation that she received an injection (Deca-durabolin) during medical treatment and did not intend to dope WADA appealed to CAS, seeking: * A four-year period of ineligibility, * Disqualification of results from 21 September 2021 until the CAS award. The Athlete did not participate in the CAS proceedings.
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)